C
Catherine L. Webb
Researcher at University of Michigan
Publications - 55
Citations - 5443
Catherine L. Webb is an academic researcher from University of Michigan. The author has contributed to research in topics: Heart disease & Calcification. The author has an hindex of 30, co-authored 55 publications receiving 4941 citations. Previous affiliations of Catherine L. Webb include University of California, San Francisco & Northwestern University.
Papers
More filters
Journal ArticleDOI
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2
Bart Loeys,Junji Chen,Enid Neptune,Daniel P. Judge,Megan Podowski,Tammy M. Holm,Jennifer Meyers,Carmen C. Leitch,Nicholas Katsanis,Neda A. Sharifi,F Lauren Xu,Loretha Myers,Philip J. Spevak,Duke E. Cameron,Julie De Backer,Jan Hellemans,Yan Chen,Elaine C. Davis,Catherine L. Webb,Wolfram Kress,Paul Coucke,Daniel B. Rifkin,Anne De Paepe,Harry C. Dietz +23 more
TL;DR: These data definitively implicate perturbation of TGFβ signaling in many common human phenotypes, including craniosynostosis, cleft palate, arterial aneurysms, congenital heart disease and mental retardation, and suggest that comprehensive mechanistic insight will require consideration of both primary and compensatory events.
Journal ArticleDOI
Genetic Basis for Congenital Heart Defects: Current Knowledge A Scientific Statement From the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young
Mary Ella M Pierpont,Craig T. Basson,D. Woodrow Benson,Bruce D. Gelb,Therese M. Giglia,Elizabeth Goldmuntz,Glenn McGee,Craig Sable,Deepak Srivastava,Catherine L. Webb +9 more
TL;DR: It is anticipated that this summary will update a wide range of medical personnel about the genetic aspects of congenital heart disease and will encourage an interdisciplinary approach to the child and adult with congenitals heart disease.
Journal ArticleDOI
Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young
Kathy J. Jenkins,Adolfo Correa,Jeffrey A. Feinstein,Lorenzo D. Botto,Amy E. Britt,Stephen R. Daniels,Marsha Elixson,Carole A. Warnes,Catherine L. Webb +8 more
TL;DR: In this article, the authors summarized the currently available literature on potential fetal exposures that might alter risk for cardiovascular defects and highlighted definitive risk factors such as maternal rubella; phenylketonuria; pregestational diabetes; exposure to thalidomide, vitamin A cogeners, or retinoids; and indomethacin tocolysis.
Journal ArticleDOI
Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing
Victoria L. Vetter,Josephine Elia,Christopher C. Erickson,Stuart Berger,Nathan J. Blum,Karen Uzark,Catherine L. Webb +6 more
TL;DR: In this article, the authors reviewed the literature relevant to this topic since the last publication of the American Heart Association (AHA) scientific statement “Cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic Drugs.
Journal ArticleDOI
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease A Scientific Statement From the American Heart Association
Therese M. Giglia,M. Patricia Massicotte,James S. Tweddell,Robyn J. Barst,Mary E. Bauman,Christopher C. Erickson,Timothy F. Feltes,Elyse Foster,Kathleen Hinoki,Rebecca Ichord,Jacqueline Kreutzer,Brian W. McCrindle,Jane W. Newburger,Sarah Tabbutt,Jane L. Todd,Catherine L. Webb +15 more
TL;DR: Thrombosis has long been recognized as a potentially life-threatening complication in children with congenital heart disease (CHD), children with acquired heart disease, and in adults with CHD.